The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heart attack or stroke. More ...

A large international study has found that spironolactone, a medication for high blood pressure and heart failure, does not reduce the risk of heart-related death or hospitalizations in people with ...

Please provide your email address to receive an email when new articles are posted on . In patients who had a heart attack but not left ventricular dysfunction, spironolactone did not improve a ...

LAS VEGAS, NV — A discharge prescription for the aldosterone blocker spironolactone in patients with a low ejection fraction who had been hospitalized for heart failure was not related to their ...

Spironolactone tablets are indicated for the treatment of heart failure, hypertension and certain cases of edema. Generic Wellbutrin (SR) is an aminoketone antidepressant indicated for the treatment ...

Please provide your email address to receive an email when new articles are posted on . A potassium binder enabled more patients with heart failure to stay on ...

Basic research on blood pressure has led researchers from Inserm (Inserm Unit 1138, "Cordeliers Research Centre") to obtain unexpected results: drugs used to treat hypertension (high blood pressure) ...

CHICAGO -- Treatment with the potassium binder sodium zirconium cyclosilicate (SZC; Lokelma) stabilized potassium levels among patients with heart failure with reduced ejection fraction (HFrEF) during ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

In patients with heart failure with mildly reduced or preserved ejection fraction (HFmrEF/HFpEF), adding the mineralocorticoid receptor antagonist (MRA) spironolactone to the SGLT2 inhibitor, ...